NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
NeuroSense and PhaseV are collaborating to use causal machine learning for clinical trial analysis and optimization of NeuroSense’s ALS therapy. The therapy, PrimeC, is…
NeuroSense Therapeutics and PhaseV have partnered to use causal machine learning to analyze and optimize the planned Phase 3 trial of PrimeC as a…
NeuroSense partners with PhaseV to use advanced causal machine learning in their upcoming Phase 3 trial for PrimeC as a treatment for ALS. PhaseV’s…
Login below or Register Now.
Already registered? Login.